Koen Vercauteren

Medicine & Life Sciences

1. Hepacivirus 100%
2. Virus Diseases 36%
3. Antiviral Agents 35%
4. Hepatocytes 19%
5. Monoclonal Antibodies 18%
6. Hepatitis E virus 18%
7. Liver 17%
8. Virion 15%
9. Infection 13%
10. lysosomal Pro-X carboxypeptidase 12%
11. Viruses 12%
12. Hepatitis C Antibodies 12%
13. CD36 Antigens 12%
14. fibroblast activation protein alpha 11%
15. Life Cycle Stages 11%
16. Peptide Hydrolases 11%
17. Monkeypox virus 11%
18. In Vitro Techniques 11%
19. Animal Models 11%
20. Influenzavirus C 11%
21. prolyl oligopeptidase 10%
22. Liver Transplantation 10%
23. Carboxypeptidase B2 10%
24. Virus-Like Particle Vaccines 10%
25. Virus Internalization 10%
26. Lipoproteins 10%
27. HIV 10%
28. Genotype 10%
29. Liver Diseases 10%
30. Flunarizine 9%
31. Coronavirus Infections 9%
32. Claudin-1 9%
33. Classical Complement Pathway 9%
34. Alternative Complement Pathway 9%
35. Belgium 9%
36. Dipeptidyl Peptidase 4 9%
37. Animal Diseases 8%
38. Severe Acute Respiratory Syndrome 8%
39. Coronavirus 8%
40. Hepatitis C 8%
41. Neutralizing Antibodies 8%
42. Sexual Health 7%
43. Capsid 7%
44. Therapeutics 7%
45. Tyrosine 7%
46. Apolipoproteins E 7%
47. Syphilis 7%
48. Interleukins 7%
49. Proline 7%
50. Hemolysis 6%